Holen Sie sich die Stockscreener-App
14.35
0.63%
0.09
Handel nachbörslich:
14.35
Finanzdaten der Wave Life Sciences Ltd-Aktie (WVE)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
56.85%
12.54
|
29.06 | 49.21 | 22.11 | 12.93 |
Operating Expenses
|
1.55%
47.00
|
47.74 | 44.77 | 45.58 | 43.21 |
| Benefits Costs and Expenses |
2.68%
44.10
|
45.31 | 42.64 | 43.21 | 40.33 |
| Costs And Expenses |
2.68%
44.10
|
45.31 | 42.64 | 43.21 | 40.33 |
| Operating Income/Loss |
84.44%
-34.46
|
-18.68 | 4.444 | -23.47 | -30.29 |
| Nonoperating Income/Loss |
19.54%
2.90
|
2.426 | 2.131 | 2.369 | 2.88 |
| Income/Loss From Continuing Operations Before Tax |
94.13%
-31.56
|
-16.26 | 6.575 | -21.10 | -27.41 |
| Income Tax Expense/Benefit |
-
|
- | -0.677 | - | - |
| Income/Loss From Continuing Operations After Tax |
94.13%
-31.56
|
-16.26 | 7.252 | -21.10 | -27.41 |
|
Net Income/Loss
|
94.13%
-31.56
|
-16.26 | 7.252 | -21.10 | -27.41 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
8,144%
129.27
|
1.568 | 106.03 | 105.46 | 102.06 |
| Diluted Average Shares |
8,144%
129.27
|
1.568 | 106.98 | 105.46 | 102.06 |
| Basic Earnings Per Share |
60.00%
-0.24
|
-0.15 | 0.07 | -0.20 | -0.27 |
| Diluted Earnings Per Share |
60.00%
-0.24
|
-0.15 | 0.07 | -0.20 | -0.27 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | -0.257 | - | - |
0.93%
3.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):